2010•TransplantationRequires access

EFFICACY AND SAFETY OF STEROID-FREE IMMUNOSUPPRESSION WITH TACROLIMUS AND DACLIZUMAB IN LIVER TRANSPLANT RECIPIENTS. SIX YEARS FOLLOW-UP IN A SINGLE CENTRE.

Bartosz Foroncewicz, Krzysztof Mucha, E. Ryszkowska, Marek Krawczyk, Leszek Pączek

Open publisher page 2 citations

Abstract

Foroncewicz, B.1; Mucha, K.1; Ryszkowska, E.1; Krawczyk, M.2; Paczek, L.3 Author Information

About this research paper

What this paper is about

Foroncewicz, B.1; Mucha, K.1; Ryszkowska, E.1; Krawczyk, M.2; Paczek, L.3 Author Information

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Foroncewicz, B.1; Mucha, K.1; Ryszkowska, E.1; Krawczyk, M.2; Paczek, L.3 Author Information

Key concepts: Daclizumab, Tacrolimus, Immunosuppression, Medicine, Internal medicine, Liver transplantation, Gastroenterology, Urology

Back to paper search Browse research topics Original source

EFFICACY AND SAFETY OF STEROID-FREE IMMUNOSUPPRESSION WITH TACROLIMUS AND DACLIZUMAB IN LIVER TRANSPLANT RECIPIENTS. SIX YEARS FOLLOW-UP IN A SINGLE CENTRE. — Research Paper | ScholarLens

EFFICACY AND SAFETY OF STEROID-FREE IMMUNOSUPPRESSION WITH TACROLIMUS AND DACLIZUMAB IN LIVER TRANSPLANT RECIPIENTS. SIX YEARS FOLLOW-UP IN A SINGLE CENTRE.

About this research paper

What this paper is about

Why it matters

Key contribution

Method / approach

Main findings

Limitations

Applications

Available abstract

Related papers